[Myeloproliferative diseases caused by JAK2 mutation].

Abstract excerpt

Polycythemia vera (PV), essential thrombocythemia(ET), and primary myelofibrosis (PMF) share common clinical features, being clonal disorders of multipotent progenitors. In 2005, a somatic activating mutation in JAK2 (V617F) was identified in most patients with PV and in about half of patients with ET or PMF. The JAK2 mutation causes the constitutive activation of the JAK-STAT signaling pathway, and leads to...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to JAK2 gene
• Share to Janus Kinase 2
• Share to Mutation